We identified that the protein ERK2 (MAPK1), one of the regulators responsible for normal and tumor cell proliferation [18, 19], can mediate activation of 79% of these pathways in viable RE-inhibited cells, as shown by the deep molecular pathway analysis using the OncoFinder method [20, 21]. This evidence concerns the gene MAPK1 and neoplasm.